Brief: Addex Therapeutics Expands Pipeline For Treatment Of Schizophrenia & Other Psychotic Disorders

Addex Therapeutics

06/04/2022 06:03

April 6 (Reuters) - ADDEX THERAPEUTICS LTD  ADXN.S :
    * REG-ADDEX EXPANDS PIPELINE WITH SELECTIVE M4 POSITIVE
ALLOSTERIC
MODULATOR PROGRAM FOR THE TREATMENT OF SCHIZOPHRENIA & OTHER
PSYCHOTIC DISORDERS
    * EXPANDS PIPELINE WITH SELECTIVE M4 POSITIVE ALLOSTERIC
MODULATOR
PROGRAM FOR TREATMENT OF SCHIZOPHRENIA & OTHER PSYCHOTIC
DISORDERS
    * THESE NOVEL SERIES OF COMPOUNDS HAVE RAPIDLY PROGRESSED
INTO
LEAD OPTIMIZATION AND ARE ANTICIPATED TO ENTER CLINICAL
CANDIDATE SELECTION PHASE IN 2023

Source text for Eikon:  ID:nGNE6bzZKb 
Further company coverage:  ADXN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))